Breaking News

Pluristyx Launches PluriFreeze Cryopreservation Media

Designed to support cell metabolism and ease pluripotent stem and other energetically active cells to and from the frozen state.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Pluristyx, a provider of tools, technologies, and services for cell therapies, has released its cryopreservation medium solution, PluriFreeze. Currently available in a Research Use Only (RUO) formulation, with a Good Manufacturing Practice (GMP) version to be released in future, PluriFreeze adds to the company’s Pluristyx’s panCELLa Platform for iPSC therapeutic development, with broad applicability for other sensitive cell types.   PluriFreeze is designed to support cell metabolism and ease p...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters